EyeCon 2026 Banner
|Articles|December 1, 2004

Miravant selects new name for SnET2

Santa Barbara, CA-Miravant Medical Technologies has picked Photrex as the brand name for its tin ethyl etiopurpurin (SnET2) drug being developed for photodynamic therapy in the treatment of wet AMD.


Latest CME